Active Pharmaceutical Ingredient (API) Supply for Venlafaxine

The contract pertains to the supply of bulk Venlafaxine Hydrochloride Active Pharmaceutical Ingredient (API) for use in pharmaceutical formulation and bottling processes, adhering strictly to current Good Manufacturing Practices (cGMP) and FDA Drug Master File (DMF) regulatory standards. The API will be provided under a subcontract arrangement, with the Defense Logistics Agency acting as the contracting authority under the Department of Defense, and the NAICS code 325320 identifies the industry as pharmaceutical and medicine manufacturing. The product must meet all quality, purity, and documentation requirements necessary for FDA compliance to ensure the final dosage form is safe, effective, and suitable for distribution in the U.S. market. The contract was posted on July 15, 2026, and is associated with the procurement reference SPE2DX25D9900 and delivery order SPE2DP26F7715, indicating it is part of a broader defense or federal healthcare supply chain initiative. Performance of the contract does not specify a geographic location, implying that manufacturing and delivery may occur at the supplier’s cGMP-compliant facility, with the API destined for U.S.-based formulation and packaging sites. All shipments and documentation must be fully traceable and compliant with FDA expectations, and the supplier is expected to maintain ongoing adherence to regulatory obligations throughout the term of the agreement.